Relationship between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes

European Urology

Volumn 69, Issue 3, 2016, Pages 512-517

  Meng, Xiaosong ^a   Rosenkrantz, Andrew B ^b   Mendhiratta, Neil ^b   Fenstermaker, Michael ^b   Huang, Richard ^a   Wysock, James S ^a,c   Bjurlin, Marc A ^a,d   Marshall, Susan ^a   Deng, Fang Ming ^a   Zhou, Ming ^a   Melamed, Jonathan ^a   Huang, William C ^a   Lepor, Herbert ^a   Taneja, Samir S ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK HOSPITAL QUEENS   (United States)

^d ST BARNABAS HOSPITAL   (United States)

Author keywords

Magnetic resonance imaging targeted prostate biopsy; Magnetic resonance imaging ultrasound fusion; Prostate biopsy; Prostate cancer; Prostate magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CANCER DIAGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAGNETIC RESONANCE IMAGING-ULTRASOUND FUSION-GUIDED PROSTATE BIOPSY DEVICE; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING ULTRASOUND FUSION TARGETED PROSTATE BIOPSY; PATIENT REFERRAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RETROSPECTIVE STUDY; SYSTEMATIC BIOPSY; CANCER GRADING; COMPARATIVE STUDY; IMAGE GUIDED BIOPSY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTATE TUMOR; REPRODUCIBILITY; RISK FACTOR;

AGED; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84931858638     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.06.005     Document Type: Article

References (21)

1. S.S. Salami, E. Ben-Levi, O. Yaskiv, and et al. In patients with a previous negative prostate biopsy and a suspicious lesion on MRI, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115 2015 562 570
2. M.R. Pokorny, M. De Rooij, E. Duncan, and et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies Eur Urol 66 2014 22 29
3. N. Arumainayagam, H.U. Ahmed, C.M. Moore, and et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard Radiology 268 2013 761 769
4. H.U. Ahmed, A. Kirkham, M. Arya, and et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6 2009 197 206
5. J.S. Wysock, A.B. Rosenkrantz, W.C. Huang, and et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial Eur Urol 66 2013 343 351
6. A.B. Rosenkrantz, S.M. Scionti, S. Mendrinos, and S.S. Taneja Role of MRI in minimally invasive focal ablative therapy for prostate cancer Am J Roentgenol 197 2011 W90 W96
7. T.H. Kuru, M.C. Roethke, P. Rieker, and et al. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate BJU Int 112 2013 1080 1087
8. T. Kim, J. Jeong, S. Lee, and et al. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance Eur Radiol 25 2015 1786 1792
9. A.B. Rosenkrantz, S. Kim, R.P. Lim, and et al. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales Radiology 269 2013 482 492
10. A.B. Rosenkrantz, R.P. Lim, M. Haghighi, M.B. Somberg, J.S. Babb, and S.S. Taneja Comparison of interreader reproducibility of the Prostate Imaging Reporting and Data System and Likert scales for evaluation of multiparametric prostate MRI Am J Roentgenol 201 2013 W612 W618
11. N.B. Delongchamps, M. Peyromaure, A. Schull, and et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies J Urol 189 2013 493 499
12. M.R. Pokorny, M. de Rooij, E. Duncan, and et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies Eur Urol 66 2014 22 29
13. G.A. Sonn, E. Chang, S. Natarajan, and et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen Eur Urol 65 2014 809 815
14. M. Siddiqui, S. Rais-Bahrami, B. Turkbey, and et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JAMA 313 2015 390 397
15. M. Valerio, I. Donaldson, M. Emberton, and et al. Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review Eur Urol 68 2015 8 19
16. T.H. Kuru, M.C. Roethke, J. Seidenader, and et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer J Urol. 190 2013 1380 1386
17. T. Penzkofer, K. Tuncali, A. Fedorov, and et al. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study Radiology 274 2014 170 180
18. J.J. Tosoian, B.J. Trock, P. Landis, and et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
19. S.P. Porten, J.M. Whitson, J.E. Cowan, and et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance J Clin Oncol 29 2011 2795 2800
20. M. Bul, R.C.N. van den Bergh, A. Rannikko, and et al. Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program Eur Urol 61 2012 370 377
21. S. Loeb, Y. Folkvaljon, D.V. Makarov, O. Bratt, A. Bill-Axelson, and P. Stattin Five-year nationwide follow-up study of active surveillance for prostate cancer Eur Urol 67 2015 233 238